相似文献
1
Captopril for refractory hypertension in patients with impaired renal function.
J R Soc Med. 1985 May;78(5):367-72. doi: 10.1177/014107688507800504.
2
Captopril in treatment-resistant essential and renal hypertension.
Scand J Urol Nephrol. 1982;16(3):243-9. doi: 10.3109/00365598209179761.
3
Clinical experience with captopril in the treatment of severe drug-resistant hypertension.
Am J Cardiol. 1982 Apr 21;49(6):1475-9. doi: 10.1016/0002-9149(82)90363-0.
4
Long-term efficacy of captopril in renovascular and essential hypertension.
Am J Cardiol. 1982 Apr 21;49(6):1440-6. doi: 10.1016/0002-9149(82)90358-7.
5
Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
Am J Nephrol. 1982;2(1):6-11. doi: 10.1159/000166575.
6
[Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
Rev Clin Esp. 1981 Sep 30;162(6):265-8.
7
Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
Am J Cardiol. 1982 Apr 21;49(6):1467-74. doi: 10.1016/0002-9149(82)90362-9.
8
The antihypertensive effect of captopril in severe essential, renovascular, renal and transplant renovascular hypertension.
Klin Wochenschr. 1982 Aug 16;60(16):839-46. doi: 10.1007/BF01728350.
9
Effects of captopril on renal function in hypertensive patients.
Am J Cardiol. 1982 Apr 21;49(6):1572-3. doi: 10.1016/0002-9149(82)90394-0.
10
Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
Isr J Med Sci. 1982 May;18(5):597-602.
引用本文的文献
1
Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.
Drugs. 1988 Nov;36(5):540-600. doi: 10.2165/00003495-198836050-00003.
2
[Results of a 5-year study with captopril in patients with severe therapy-resistant hypertension].
Klin Wochenschr. 1986 Aug 1;64(15):695-700. doi: 10.1007/BF01712054.
3
Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal disease.
Cardiovasc Drugs Ther. 1990 Feb;4(1):221-8. doi: 10.1007/BF01857636.
4
Angiotensin-converting enzyme inhibitors in chronic renal failure.
Drugs. 1990;39 Suppl 2:23-32. doi: 10.2165/00003495-199000392-00006.
本文引用的文献
1
Clinical experience with captopril in the treatment of severe drug-resistant hypertension.
Am J Cardiol. 1982 Apr 21;49(6):1475-9. doi: 10.1016/0002-9149(82)90363-0.
2
Sodium intake and renal responses to captopril in normal man and in essential hypertension.
Kidney Int. 1981 Aug;20(2):240-5. doi: 10.1038/ki.1981.126.
3
Captopril for refractory hypertension in patients with chronic renal failure and renal transplantation.
J R Soc Med. 1981 May;74(5):357-62.
4
Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.
Drugs. 1980 Dec;20(6):409-52. doi: 10.2165/00003495-198020060-00001.
5
Fatal pancytopenia associated with the use of captopril.
Ann Intern Med. 1981 Jan;94(1):58-9. doi: 10.7326/0003-4819-94-1-58.
6
Prostaglandins, kinins and the regulation of blood pressure.
Clin Exp Hypertens (1978). 1980;2(3-4):729-40. doi: 10.3109/10641968009037139.
7
Nephrotic syndrome from captopril.
S Afr Med J. 1980 Mar 15;57(11):390.
8
Hemodynamic and volume changes associated with captopril.
Hypertension. 1980 Jul-Aug;2(4):576-85. doi: 10.1161/01.hyp.2.4.576.
9
Proteinuria during long-term captopril therapy.
JAMA. 1980 Jul 25;244(4):346-9.
10
Captopril in severe treatment-resistant hypertension.
Am Heart J. 1980 May;99(5):579-85. doi: 10.1016/0002-8703(80)90730-9.
Zotero 插件